Tocilizumab and rituximab for anti-MDA-5 positive amyopathic dermatomyositis complicated with macrophage activation syndrome and progressive fibrosing interstitial lung disease

C. F. Su, H. T. Liao, C. Y. Tsai

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)166-168
Number of pages3
JournalScandinavian Journal of Rheumatology
Volume51
Issue number2
DOIs
Publication statusPublished - 2022

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology

Cite this